Enhancing Bone Health with Conjugated Linoleic Acid: Mechanisms, Challenges, and Innovative Strategies DOI Open Access

Khandoker Hoque,

Zayana Ali,

Asma Maliha

et al.

Nutrients, Journal Year: 2025, Volume and Issue: 17(8), P. 1395 - 1395

Published: April 21, 2025

Conjugated linoleic acid (CLA) is a bioactive compound known for its anti-inflammatory, anti-carcinogenic, and metabolic effects, with growing interest in role supporting bone health. Preclinical studies, particularly those involving the t10c12 isomer, have shown that CLA can enhance mineral density (BMD) by enhancing formation reducing resorption, indicating potential as therapeutic agent to improve However, clinical trials yielded inconsistent results, underscoring difficulty translating animal model successes human applications. A major challenge CLA’s low water solubility, poor absorption, limited bioavailability, which restrict effectiveness. To address these issues, nanoparticle-based delivery systems been proposed stability, resistance oxidative damage, thereby bioactivity. Recent studies also suggest electrical stimulation stimulate regeneration promoting cell proliferation, differentiation, adherence scaffolds. This review explores combined use of supplementation novel approach improving health, osteoporosis management. By integrating biological effects regenerative stimulation, this multimodal strategy offers promising method restoration, significant implications applications

Language: Английский

Vesicular Carriers for Phytochemical Delivery: A Comprehensive Review of Techniques and Applications DOI Creative Commons
Shery Jacob, Fathima Sheik Kather, Sai H. S. Boddu

et al.

Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(4), P. 464 - 464

Published: April 2, 2025

Natural substances, especially those derived from plants, exhibit a diverse range of therapeutic benefits, such as antioxidant, anti-inflammatory, anticancer, and antimicrobial effects. Nevertheless, their use in clinical settings is frequently impeded by inadequate solubility, limited bioavailability, instability. Nanovesicular carriers, liposomes, niosomes, ethosomes, transferosomes, transethosomes, cubosomes, have emerged innovative phytochemical delivery systems to address these limitations. This review highlights recent developments vesicular nanocarriers for delivery, emphasizing preparation techniques, composition, applications, the future potential systems. Phytosomes, along with key advantages various are extensively described. Various vitro vivo characterization techniques utilized evaluating nanovesicular carriers summarized. Completed trials patents granted nanovesicles encapsulating phytochemicals designed systemic tabulated. Phytochemical via faces challenges low stability, active loading, scalability issues, high production costs. Additionally, immune clearance regulatory hurdles hinder application, requiring improved carrier design formulation techniques.

Language: Английский

Citations

0

ENHANCING SOLUBILITY AND PERMEABILITY OF HYDROCHLOROTHIAZIDE USING SOLID LIPID NANOPARTICLES DOI
Vidya Sabale, Roshan Telrandhe,

Ashwini Ingole

et al.

INDIAN DRUGS, Journal Year: 2025, Volume and Issue: 62(03), P. 26 - 37

Published: March 28, 2025

Hydrochlorothiazide, a poorly soluble and also permeable drug of BCS class IV, was formulated into solid lipid nanoparticles (SLNs) using the microemulsion method. Precirol® ATO 5, Tween® 80 Kolliphor® P 188 were employed as lipid, surfactant co-surfactant, respectively. Optimization 23 factorial design explored concentration (A), (B) stirring time (C) independent variables, particle size (Y1), % entrapment efficiency (Y2), release (Y3) responses. FTIR DSC demonstrated drug-excipient compatibility. The optimized SLNs showed 12-fold water solubility increase, 94.75±0.0026 content, 91.23±0.29 efficiency, 35.06±0.0019 loading sustained zero order release. A permeation study revealed enhanced flux (166.14±0.013µg cm-2h) permeability coefficient (83.07±0.031 cm h-1) compared to pure drug. SEM uniform, smooth particles, while XRD confirmed SLN’s amorphous nature. These results show potential significantly enhance hydrochlorothiazide’s permeability.

Language: Английский

Citations

0

Targeted Drug Delivery System for Pulmonary Fibrosis: Design and Development of Biomaterials DOI Creative Commons
Jinsha Liu,

Zifeng Pan,

Aatif Khan

et al.

BIO Integration, Journal Year: 2025, Volume and Issue: 6(1)

Published: Jan. 1, 2025

Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and tissue scarring, leading to impaired function respiratory failure. Although current treatments, such as pirfenidone nintedanib, slow progression, they fail completely halt or reverse fibrosis. Therefore, innovative therapeutic strategies are needed. Targeted drug delivery systems (TDDSs) emerging promising solutions. Biomaterials play critical roles in these enhancing specificity, availability, efficacy, while minimizing systemic toxicity. The most notable biomaterials include nanotechnology-based systems, including liposomes polymeric nanoparticles, which facilitate penetration release fibrotic tissues. Hydrogels have three-dimensional structures providing controlled sustained at inflammation sites, therefore particularly valuable PF treatment. Furthermore, biological carriers stem cells vesicles biocompatibility anti-inflammatory effects that improve outcomes. Despite the potential of clinical translation hindered several challenges, immune clearance, stability platforms, optimization retention within diseased Interdisciplinary approaches integrating precision medicine with advancements may provide solutions opening new avenues for This review discusses developments targeted PF, emphasizing importance biomaterials, mechanisms barriers involved pulmonary delivery, future perspectives overcoming limitations. ultimate goal patient outcomes revolutionizing approach treatment through advanced technologies.

Language: Английский

Citations

0

Exploring Oxidative Stress Mechanisms of Nanoparticles Using Zebrafish (Danio rerio): Toxicological and Pharmaceutical Insights DOI Creative Commons
Denisa Batîr-Marin, Monica Boev, Oana Cioancă

et al.

Antioxidants, Journal Year: 2025, Volume and Issue: 14(4), P. 489 - 489

Published: April 18, 2025

Nanoparticles (NPs) have revolutionized biomedical and pharmaceutical applications due to their unique physicochemical properties. However, widespread use has raised concerns regarding potential toxicity, particularly mediated by oxidative stress mechanisms. This redox imbalance, primarily driven the overproduction of reactive oxygen species (ROS), plays a central role in NP-induced leading cellular dysfunction, inflammation, apoptosis, genotoxicity. Zebrafish (Danio rerio) emerged as powerful vivo model for nanotoxicology, offering advantages such genetic similarity humans, rapid development, optical transparency, allowing real-time monitoring damage. review synthesizes current findings on zebrafish, highlighting key toxicity mechanisms case studies involving metallic (gold, silver, copper), metal oxide (zinc oxide, titanium dioxide, iron oxide), polymeric, lipid-based NPs. The influence NP properties, size, surface charge, functionalization, responses is explored. Additionally, experimental approaches used assess ROS generation, antioxidant enzyme activity, damage biomarkers zebrafish models are examined. In addition concerns, antioxidant-modified NPs evaluated, drug delivery, neuroprotection, disease therapeutics. Notably, show that curcumin- quercetin-loaded nanoparticles enhance defense reduce neurotoxicity models, demonstrating promise neuroprotective therapies. Furthermore, cerium nanoparticles, which mimic catalase SOD enzymatic shown significant efficacy reducing protecting against Challenges zebrafish-based need standardized methodologies, future directions optimizing design minimize stress-related risks also discussed. By integrating insights from mechanisms, studies, strategies, this supports development safer more effective nanoparticle-based therapies while addressing challenges toxicity.

Language: Английский

Citations

0

Enhancing Bone Health with Conjugated Linoleic Acid: Mechanisms, Challenges, and Innovative Strategies DOI Open Access

Khandoker Hoque,

Zayana Ali,

Asma Maliha

et al.

Nutrients, Journal Year: 2025, Volume and Issue: 17(8), P. 1395 - 1395

Published: April 21, 2025

Conjugated linoleic acid (CLA) is a bioactive compound known for its anti-inflammatory, anti-carcinogenic, and metabolic effects, with growing interest in role supporting bone health. Preclinical studies, particularly those involving the t10c12 isomer, have shown that CLA can enhance mineral density (BMD) by enhancing formation reducing resorption, indicating potential as therapeutic agent to improve However, clinical trials yielded inconsistent results, underscoring difficulty translating animal model successes human applications. A major challenge CLA’s low water solubility, poor absorption, limited bioavailability, which restrict effectiveness. To address these issues, nanoparticle-based delivery systems been proposed stability, resistance oxidative damage, thereby bioactivity. Recent studies also suggest electrical stimulation stimulate regeneration promoting cell proliferation, differentiation, adherence scaffolds. This review explores combined use of supplementation novel approach improving health, osteoporosis management. By integrating biological effects regenerative stimulation, this multimodal strategy offers promising method restoration, significant implications applications

Language: Английский

Citations

0